Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials

Philippe Gevaert, Martin Desrosiers, Marjolein Cornet, Joaquim Mullol, Eugenio De Corso, Nesil Keles Turel, Jorge Máspero, Shigeharu Fujieda, Luo Zhang, Ana R. Sousa, Samantha Woods, Angela Davis, Stein Schalkwijk, Dawn Edwards, Prerna Ranganathan, Richard Follows, Carol Marshall, Joseph K. Han